31. A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus. (May 2015) Authors: Voellmy, Richard; Bloom, David C; Vilaboa, Nuria Journal: Expert review of vaccines Issue: Volume 14:Number 5(2015) Page Start: 637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. A novel genetically engineered Mycobacterium smegmatis-based vaccine promotes anti-TB immunity. (January 2012) Authors: Jeyanathan, Mangalakumari; Thanthrige-Don, Niroshan; Xing, Zhou Journal: Expert review of vaccines Issue: Volume 11:Number 1(2012) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studies. (September 2013) Authors: Barrett, P Noel; Portsmouth, Daniel Journal: Expert review of vaccines Issue: Volume 12:Number 9(2013) Page Start: 973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. (2nd September 2021) Authors: Martinón-Torres, Federico; Bertrand-Gerentes, Isabelle; Oster, Philipp Journal: Expert review of vaccines Issue: Volume 20:Number 9(2021) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. A PE_PGRS33 protein of Mycobacterium tuberculosis: an ideal target for future tuberculosis vaccine design. (May 2015) Authors: Gastelum-Aviña, Paola; Velazquez, Carlos; Espitia, Clara; Lares-Villa, Fernando; Garibay-Escobar, Adriana Journal: Expert review of vaccines Issue: Volume 14:Number 5(2015) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. A policy review of the introduction of the MenACWY vaccine in toddlers across multiple countries. (2nd November 2022) Authors: Valmas, Charalampos; Arcà, Emanuele; Hensen, Marja; Rashid, Habeeda Journal: Expert review of vaccines Issue: Volume 21:Number 11(2022) Page Start: 1637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice. (2nd January 2017) Authors: Li, Xiangming; Huang, Jing; Kaneko, Izumi; Zhang, Min; Iwanaga, Shiroh; Yuda, Masao; Tsuji, Moriya Journal: Expert review of vaccines Issue: Volume 16:Number 1(2017) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations. (2nd September 2021) Authors: Parikh, Raunak; Widenmaier, Robyn; Lecrenier, Nicolas Journal: Expert review of vaccines Issue: Volume 20:Number 9(2021) Page Start: 1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18. (April 2012) Authors: Goldstone, Stephen E; Vuocolo, Scott Journal: Expert review of vaccines Issue: Volume 11:Number 4(2012) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. A recombinant live attenuated tetravalent vaccine for the prevention of dengue. (3rd July 2017) Authors: Guy, Bruno; Noriega, Fernando; Ochiai, R. Leon; L'azou, Maïna; Delore, Valentine; Skipetrova, Anna; Verdier, François; Coudeville, Laurent; Savarino, Stephen; Jackson, Nicholas Journal: Expert review of vaccines Issue: Volume 16:Number 7(2017) Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗